This World Zoonoses Day, we're highlighting a selection of Abbexa’s articles exploring the science behind some of the world's most significant infectious diseases, many of which begin with a jump from animals to humans: www.linkedin.com/feed/update/...

With Ebola once again making headlines, we asked our scientist, Nick Thomas, to answer some of the most common questions about the virus. Read more: www.linkedin.com/feed/update/...

Proteins and peptides are central to scientific discovery, driving progress across biology and medicine every day. For a limited time, Abbexa is offering 15% off selected proteins and peptides to support your research: www.abbexa.com/products/pro...

Unlike other hantaviruses, the Andes virus is capable of spreading from person to person - a rare trait that has renewed global attention. But how does transmission happen, and why are scientists so concerned about this virus? Read more in Abbexa's recent article: www.abbexa.com/the-only-han...

'The protocol was straightforward, the reagents were easy to prepare, and the results were consistent across samples.' — Researcher, UK Join researchers already achieving reliable results with Abbexa products and take advantage of 15% off discount before 31 May 2026: www.abbexa.com/products/eli...

Meet Abbexa at the Institute of Metabolic Science on 21 May 2026! Come and discover our latest reagents, speak directly with our scientists, and pick up free Abbexa goodies (including our popular grey felt bags). 📍IMS Tea Room, Level 4, @ims-mrl.bsky.social 📅21 May 2026, 9:30 am – 4:00 pm

Using Abbexa’s Taurine ELISA Kit, a research team from the University of California identified a compound that may affect taurine levels in mouse blood. Enhance your research with 15% off selected ELISA, CLIA, and primary antibodies before 31 May: www.abbexa.com/products/eli...

Open role at Abbexa: Regulatory Affairs Officer This is a fantastic opportunity for a regulatory professional with strong experience in Medical Devices regulatory frameworks. Read more about the role and apply here: www.abbexa.com/regulatory-a...

A smarter way to study treatment resistance in cancer is emerging through 3D spheroid models. Read a new article by Hailey Sze, PhD Researcher at @qmul.bsky.social, to explore how these models are transforming research into Head and Neck Squamous Cell Carcinoma: www.abbexa.com/a-smarter-wa...

Our first time at the Microbiology Society conference was a memorable one! So nice to meet so many microbiologists working on such impactful research. Huge thanks to everyone who supported us, and to the @microbiologysociety.org team for an excellent event. Hope to be back in 2027! #Microbio26

Our team is at #AACR26, ready to talk to you about our ELISA kits, antibodies, proteins and peptides that can support your research in the fight against #cancer. Stop by stand #3452 and pick up one of our famous grey bags before they're gone!

Rainy day in Belfast today but fear not, Abbexa still have a few umbrellas! If you’re in Belfast, come and say hello to our team at the Microbiology Society Annual Conference. We’ll be at stand 12 until Thursday, April 16. #Microbio26 #Microbiology #Abbexa @microbiologysociety.org

Get 15% off some of our top-selling CLIA Kits: · Human Thyroglobulin (TG) CLIA Kit · Human Angiopoietin 1 (ANG1) CLIA Kit · Mouse Tumor Protein (TCTP1) CLIA Kit and more! 🔗 Offer ends on the 31st of May: www.abbexa.com/products/eli... #CLIAkit #ELISAkit

Get high quality antibodies with 15% off, including products from Abbexa’s top 100 bestsellers list: 🔬 Mucin-21 (MUC21) Antibody 🔬 Defensin Alpha 5, Paneth Cell Specific (DEFA5) Antibody Explore all available products with 15% off: www.abbexa.com/products/eli... #ELISAkit #Antibody

Known as a hereditary risk marker, BRCA1 safeguards our genome by promoting DNA repair, meaning that without this gene, tumour cells can grow more easily. Mutations in this gene are strongly associated with the development of breast cancer.

One highlight from our Top-100 range is the Human Aspartoacylase (ASPA) ELISA Kit (Catalogue No: abx519903). It’s now available at 15% off. Discover the full promotion on our website and see which other ELISA, CLIA, and antibodies are included: www.abbexa.com/products/eli... #Abbexa #ELISAkit

Get 15% Off Selected ELISA Kits, CLIA Kits, and Primary Antibodies: www.abbexa.com/products/eli... Offer ends 31 May 2026. Stock up today and keep your research moving.

Curiosity drives scientific progress, and having specific, reliable tools helps researchers get clear, dependable results. With AACR on the horizon, we’re highlighting our range of cancer research essentials, featuring hundreds of cited products Our collection: www.abbexa.com/products/ess...

Accounting for approximately 15% of breast cancer cases, Triple Negative Breast Cancer is one of the most difficult cancers to treat. This is due to the lack of hormonal and molecular markers targeted by modern therapies.

Abbexa will be exhibiting at the Microbiology Society Annual Conference 2026, taking place from 13–16 April at the ICC Belfast. Come and meet our team to see how we can support your work in microbiology. And of course, our infamous grey felt bags and golf umbrellas will be there too! #Microbio26

The Mucin 21 (MUC21) Antibody continues to gain attention in cancer research, and a 2024 study highlights why: researchers suggest that MUC21 may be a potential new target for tumour treatment.

We were delighted to represent Abbexa at the Cambridge Biomedical Campus Careers Fair! It was great meeting so many talented people and discussing careers in life sciences. If you’d like to learn more about working at Abbexa, take a look at our careers page: www.abbexa.com/careers

Understanding the complexity of the tumour microenvironment is essential for advancing cancer diagnostics and treatment.

Recent research highlights the pivotal roles that members of the UNC13 family have been observed to play in various types of diseases, including different types of cancer.

With a survival rate of only 13% across all stages, pancreatic cancer remains one of the deadliest cancers. However, the latest research has revealed that scientists have been able to cure pancreatic cancer in mice.

Only 3 days left to save 20% on biosimilars If biosimilars are part of your research, now is the moment to optimise your budget without compromising on quality. Explore 600+ biosimilars at a reduced price: www.abbexa.com/products/bio... Orders must be placed before 28 February 2026. T&Cs apply.

Being one of the largest and most influential research conferences in the world, AACR is a platform for researchers worlwide to share the latest breakthroughs driving us forward in the battle against cancer. Find our team at booth #3452 to discuss new insights to your research.

On the International Day of Women and Girls in Science, women at Abbexa shared their science journeys and what inspired them. 🧪Read their stories here: bit.ly/4qvddAa #WomenInScience #Abbexa

With cancer influencing millions of lives in countless ways, behind every diagnosis is a unique story. Rare cancers make up for 30% of total cancer related deaths. The need for specialised research in these areas is vital to address the global burden of cancer.

Get top-performing biosimilars with 20% off 🔬 Abbexa biosimilars deliver consistency, validated performance & expert scientific support at a lower cost. ⏳ Offer ends by the end of February: bit.ly/3O3S4iN #Biosimilars #LifeScienceResearch #Abbexa